Literature DB >> 6792353

Inadequate corpus luteum function after the induction of ovulation in anoestrous ewes by LH-RH or an LH-RH agonist.

A S McNeilly, M Hunter, R B Land, H M Fraser.   

Abstract

Scottish Blackface ewes were given LH-RH (3 x 30 micrograms i.v., at 90 min intervals) or D-Ser-(But)6-des Gly10 LH-Rh ethylamide (LH-RH agonist) as a single injection (8 or 40 micrograms) during anoestrus. Ovulation as judged by laparoscopy occurred in 8 of the 27 animals. Despite the fact that the LH-RH agonist induced a greater release of LH and FSH the different treatments had no effect on the number of ewes ovulating and within each treatment group there was no apparent difference in the amounts of gonadotrophins released between the ewes that did or did not ovulate. All ovulations resulted in the formation of CL associated with plasma progesterone concentrations of less than 1 ng/ml (1--5 ng/ml in the normal luteal phase). In comparison with CL of the normal cycle the induced CL were of lower weight and had reduced progesterone content and ability to secrete progesterone in vitro. However, the binding of hCG was equivalent to that of normal CL. These results suggest that the inadequate CL formed in anoestrous ewes after a single LH-RH injection have not developed the ability to synthesize and secrete progesterone in spite of the presence of normal amounts of LH receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6792353     DOI: 10.1530/jrf.0.0630137

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  2 in total

1.  Trypanosomosis and reproduction: I. Effect of Trypanosoma vivax infection on the oestrous cycle and fertility in the ewe.

Authors:  E Elhassan; B O Ikede; O Adeyemo
Journal:  Trop Anim Health Prod       Date:  1994-11       Impact factor: 1.559

2.  Plasma levels of luteinizing hormone, estradiol and androstenedione in sows with inadequate plasma progesterone.

Authors:  R Pierantoni; A R Genazzani; L Perotti; G Enne; P Inaudi; M d'Istria; M A Musarò; F Citarella; S Fasano; G Delrio
Journal:  J Endocrinol Invest       Date:  1983-02       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.